Cargando…
Sarcopenia as a novel prognostic factor in the patients of primary localized gastrointestinal stromal tumor
BACKGROUND: Sarcopenia predicts poor prognosis of a variety of gastrointestinal malignancies. However, there is a lack of study on the association between skeletal muscle index (SMI) and the prognosis of gastrointestinal stromal tumor (GIST). The aim of this study is to develop a novel nomogram base...
Autores principales: | Song, He, Xiao, Xianhao, Liu, Gang, Zhou, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851766/ https://www.ncbi.nlm.nih.gov/pubmed/35177018 http://dx.doi.org/10.1186/s12885-022-09278-w |
Ejemplares similares
-
Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
por: Moryoussef, Frédérick, et al.
Publicado: (2015) -
A systematic review and network meta-analysis of the efficacy and safety of third-line and over third-line therapy after imatinib and TKI resistance in advanced gastrointestinal stromal tumor
por: Xiao, Xianhao, et al.
Publicado: (2022) -
Prognostic Analysis of Duodenal Gastrointestinal Stromal Tumors
por: Hong, Liwen, et al.
Publicado: (2018) -
Nomogram for Predicting Recurrence-Free Survival of Primary Localized Gastrointestinal Stromal Tumor
por: Ran, Pan, et al.
Publicado: (2023) -
Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor
por: Ling, Jiayu, et al.
Publicado: (2023)